非球面复曲面和非复曲面无晶状体人工晶状体的比较 (COAST)
The purpose of this multi-center clinical trial is to determine the safety and efficacy of the HSO Toric IOLs for the correction of aphakia and reduction of pre-existing refractive astigmatism.
研究概览
研究类型
注册 (实际的)
阶段
- 不适用
联系人和位置
学习地点
-
-
California
-
Chino Hills、California、美国、91709
- Contact Hoya Surgical Optics, Inc. for Trial Locations
-
Santa Maria、California、美国、93454
- Shepard Eye Center
-
-
Florida
-
Mt. Dora、Florida、美国、32757
- Mid-Florida Eye Center
-
-
Michigan
-
Bloomfield Hills、Michigan、美国、48302
- Grosinger, Spigelman & Grey,
-
-
Missouri
-
Dansas City、Missouri、美国、64133
- Silverstein Eye Conters
-
-
Ohio
-
Brecksville、Ohio、美国、44141
- Cleveland Eye Clinic
-
-
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
描述
Inclusion Criteria:
- Have been diagnosed with cataract for which phacoemulsification extraction and posterior chamber IOL implantation is indicated
- Have at least one eye that meets the ranges of pre-operative corneal cylinder as specified by this study's guidelines, i.e. corneal cylinder of at least 1.0 D (after accounting for changes in corneal cylinder due to the incision)
- Have potential Best Corrected Visual Acuity of 20/30 or better after implantation of a study lens
- Have clear intraocular media other than cataract
- Have preoperative Best Corrected Visual Acuity equal to 20/40 or worse, with or without a glare source
Exclusion Criteria:
- Have atonic pupils or physiologically small pupils in either eye (unable to dilate to at least 4 mm)
- Have irregular astigmatism in the operative eye, or refractive cylinder resulting only from lenticular astigmatism in the operative eye
- Have corneal pathology potentially affecting corneal topography, or other corneal abnormalities that do or are expected to reduce best corrected visual acuity in the operative eye during the study period
- Have undergone previous refractive corneal surgery in the operative eye
- Have been diagnosed with any degenerative retinal disorders (e.g. soft drusen, macular degeneration or other progressive retinal disorders) in the operative eye that are predicted to cause future visual acuity losses to a level of 20/30 or worse during the postoperative follow-up time requirements of this study
Eligibility criteria not complete. Contact Hoya Surgical Optics, Inc. for more information.
学习计划
研究是如何设计的?
设计细节
- 主要用途:治疗
- 分配:随机化
- 介入模型:并行分配
- 屏蔽:单身的
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
实验性的:NHT15
Aspheric Toric Intraocular Lens Models NHT15 |
Phacoemulsification cataract extraction followed by implantation of an aspheric toric intraocular lens: Model NHT15, NHT30, or NHT53. |
|
有源比较器:FY-60AD
Aspheric Non-toric Intraocular Lens: Model FY-60AD |
Phacoemulsification cataract extraction followed by implantation of an aspheric non-toric intraocular lens: Model FY-60AD. |
|
实验性的:NHT30
Aspheric Toric Intraocular Lens Model NHT30 |
Phacoemulsification cataract extraction followed by implantation of an aspheric toric intraocular lens: Model NHT15, NHT30, or NHT53. |
|
实验性的:NHT53
Aspheric Toric Intraocular Lens Models NHT53 |
Phacoemulsification cataract extraction followed by implantation of an aspheric toric intraocular lens: Model NHT15, NHT30, or NHT53. |
研究衡量的是什么?
主要结果指标
结果测量 |
大体时间 |
|---|---|
|
绝对柱面减少百分比
大体时间:长达 14 个月
|
长达 14 个月
|
次要结果测量
结果测量 |
大体时间 |
|---|---|
|
镜片旋转或未对准和患者满意度
大体时间:长达 14 个月
|
长达 14 个月
|
合作者和调查者
调查人员
- 研究主任:Kees den Besten、Hoya Surgical Optics, Inc.
研究记录日期
研究主要日期
学习开始
初级完成 (实际的)
研究完成 (实际的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (估计的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.